Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
Journal
Kidney international reports
Journal Volume
8
Journal Issue
11
Date Issued
2023-11
Author(s)
Ni, Zhaohui
Liang, Xinling
Wu, Chia-Chao
Jin, Kyubok
Kim, Yong-Lim
Lu, Kuo-Cheng
Chan, Tak Mao
Fukagawa, Masafumi
Kinoshita, Jun
Nagai, Chisato
Kojima, Masahiro
Yu, Xueqing
Orchestra Study Group
Abstract
Evocalcet is an oral calcimimetic agent with proven efficacy and safety in treating secondary hyperparathyroidism (SHPT) in Japanese patients on dialysis.
Subjects
East Asia; cinacalcet; evocalcet; gastrointestinal; randomized controlled trial; secondary hyperparathyroidism
SDGs
Type
journal article